Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tess Nicotra"'
Autor:
Tess Nicotra, Aurélie Desnos, Justine Halimi, Hélène Antonot, Loïc Reppel, Thomas Belmas, Alice Freton, Floriane Stranieri, Miryam Mebarki, Jérôme Larghero, Audrey Cras, Lionel Faivre
Publikováno v:
Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-10 (2020)
Abstract Background Mesenchymal stem/stromal cells (MSC) have immunomodulatory properties, studied in a wide range of diseases. Validated quality controls must confirm this activity in the context of clinical trials. This study presents a method’s
Externí odkaz:
https://doaj.org/article/a25bc0831754410883a3656fc22dbfe1
Autor:
Guadalupe Ortiz-Muñoz, Markus Brown, Catherine B. Carbone, Ximo Pechuan-Jorge, Vincent Rouilly, Henrik Lindberg, Alex T. Ritter, Gautham Raghupathi, Qianbo Sun, Tess Nicotra, Shreya R. Mantri, Angela Yang, Jonas Doerr, Deepti Nagarkar, Spyros Darmanis, Benjamin Haley, Sanjeev Mariathasan, Yulei Wang, Carlos Gomez-Roca, Carlos Eduardo de Andrea, David Spigel, Thomas Wu, Lelia Delamarre, Johannes Schöneberg, Zora Modrusan, Richard Price, Shannon J. Turley, Ira Mellman, Christine Moussion
Publikováno v:
Nature.
The immune phenotype of a tumour is a key predictor of its response to immunotherapy1–4. Patients who respond to checkpoint blockade generally present with immune-inflamed5–7 tumours that are highly infiltrated by T cells. However, not all inflam
Autor:
Loïc Reppel, Lionel Faivre, Tess Nicotra, Thomas Belmas, Justine Halimi, Floriane Stranieri, Alice Freton, Audrey Cras, Miryam Mebarki, Aurélie Desnos, Jérôme Larghero, Hélène Antonot
Publikováno v:
Stem Cell Research and Therapy
Stem Cell Research and Therapy, BioMed Central, 2020, 11 (1), ⟨10.1186/s13287-020-01947-6⟩
Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-10 (2020)
Stem Cell Research & Therapy
Stem Cell Research and Therapy, BioMed Central, 2020, 11 (1), ⟨10.1186/s13287-020-01947-6⟩
Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-10 (2020)
Stem Cell Research & Therapy
Background Mesenchymal stem/stromal cells (MSC) have immunomodulatory properties, studied in a wide range of diseases. Validated quality controls must confirm this activity in the context of clinical trials. This study presents a method’s validatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42a8966f24119b7e6b033d55547a7867
https://hal.archives-ouvertes.fr/hal-02968477
https://hal.archives-ouvertes.fr/hal-02968477